Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma

NCT02002598 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and loss of funding

Conditions

Multiple Myeloma

Interventions

DRUG: Bendamustine
DRUG: Carfilzomib
DRUG: Dexamethasone

Sponsor

Suzanne Lentzsch, MD